As of 2025-04-23, the Fair Value of Replimune Group Inc (REPL) is -14.82 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.77 USD, the upside of Replimune Group Inc is -269.07%.
With the market price of 8.77 USD and our fair value calculation, Replimune Group Inc (REPL) is not a good investment. Investing in REPL stocks now will result in a potential loss of 269.07%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 5Y Avg | |
| Net income | -52.63 | -80.87 | -118.04 | -174.28 | -215.79 | -128.32 |
| YoY growth | -70.71% | -53.66% | -45.96% | -47.64% | -23.82% | -48.36% |
| Market Cap (mil) | 674.99 |
| P/E | |
| Forward P/E |
| EPS | -2.96 |
| Avg earnings growth rate | -48.36% |
| TTM earnings | -228.24 |